Center for Drug Discovery, Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas 77030, United States.
Bioconjug Chem. 2020 Mar 18;31(3):770-780. doi: 10.1021/acs.bioconjchem.9b00863. Epub 2020 Feb 21.
DNA-encoded chemical library (DECL) screens are a rapid and economical tool to identify chemical starting points for drug discovery. As a robust transformation for drug discovery, palladium-catalyzed C-N coupling is a valuable synthetic method for the construction of DECL chemical matter; however, currently disclosed methods have only been demonstrated on DNA-attached (hetero)aromatic iodide and bromide electrophiles. We developed conditions utilizing an -heterocyclic carbene-palladium catalyst that extends this reaction to the coupling of DNA-conjugated (hetero)aromatic chlorides with (hetero)aromatic and select aliphatic amine nucleophiles. In addition, we evaluated steric and electronic effects within this catalyst series, carried out a large substrate scope study on two representative (hetero)aryl bromides, and applied this newly developed method within the construction of a 63 million-membered DECL.
DNA 编码化学文库 (DECL) 筛选是一种快速且经济的工具,可用于鉴定药物发现的化学起点。作为药物发现的一种强大转化,钯催化的 C-N 偶联是构建 DECL 化学物质的一种有价值的合成方法;然而,目前公开的方法仅在 DNA 连接的(杂)芳基碘化物和溴化物亲电子试剂上得到了证明。我们开发了利用 -杂环卡宾-钯催化剂的条件,该条件将该反应扩展到 DNA 连接的(杂)芳基氯化物与(杂)芳基和选择性脂肪族胺亲核试剂的偶联。此外,我们在该催化剂系列中评估了空间和电子效应,对两个代表性(杂)芳基溴化物进行了大规模的底物范围研究,并在 6300 万成员的 DECL 构建中应用了这种新开发的方法。